Rodrigo de Moraes Brindeiro

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biologia

Departamento:

Departamento de Genética/IB

ORCID:

não disponível no Lattes


Formação:

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Genética) | Doutorado | 1992 - 1999

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Genética) | Mestrado | 1988 - 1991

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas - modalidade Genética | Graduação | 1984 - 1987
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(57.14% artigos com DOI)

Titulo DOI Ano
Genomic and epidemiological monitoring of yellow fever virus transmission potential 10.1126/science.aat7115 2018
The spectrum of neuropathological changes associated with congenital Zika virus infection 10.1007/s00401-017-1699-5 2017
Evidence for Transmission of Zika Virus by Platelet Transfusion 10.1056/nejmc1607262 2016
Lopinavir Resistance Classification with Imbalanced Data Using Probabilistic Neural Networks 10.1007/s10916-015-0428-7 2016
Congenital Zika Virus Infection 10.1001/jamaneurol.2016.3720 2016
Zika virus impairs growth in human neurospheres and brain organoids 10.1126/science.aaf6116 2016
Follow-up on long-term antiretroviral therapy for cats infected with feline immunodeficiency virus 10.1177/1098612X15580144 2016
Gene Discovery through Transcriptome Sequencing for the Invasive Mussel Limnoperna fortunei 10.1371/journal.pone.0102973 2014
Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C 10.1371/journal.pone.0046622 2012
In Vitro-Reduced Susceptibility to Artemether in P. falciparum and Its Association With Polymorphisms on Transporter Genes 10.1093/infdis/jis359 2012
Natural transmission of feline immunodeficiency virus from infected queen to kitten 10.1186/1743-422x-9-99 2012
The Brazilian Network for HIV-1 Genotyping External Quality Control Assurance Programme 10.1186/1758-2652-14-45 2011
CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes 10.1111/j.1365-2249.2011.04319.x 2011
Enhanced Th17 Phenotype in Uninfected Neonates Born from Viremic HIV-1-Infected Pregnant Women 10.1007/s10875-010-9485-3 2011
Accumulation of P(T/S)AP Late Domain Duplications in HIV Type 1 Subtypes B, C, and F Derived from Individuals Failing ARV Therapy and ARV Drug-Naive Patients 10.1089/aid.2010.0282 2011
Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic. 2011
Failure of Highly Active Antiretroviral Therapy in Reconstituting Immune Response to Clostridium tetani Vaccine in Aged AIDS Patients 10.1097/QAI.0b013e3181d6003b 2010
HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil 10.1590/s1413-86702010000400009 2010
Genetic diversity of human immunodeficiency virus-1 isolates in Paraná, Brazil 10.1590/s1413-86702010000300006 2010
Pseudo-peptides derived from isomannide: inhibitors of serine proteases 10.1007/s00726-009-0273-4 2010
Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure? 10.1016/j.meegid.2008.10.002 2009
IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment 10.1097/QAD.0b013e328317461e 2009
Enfuvirtide (T-20) Resistance-Related Mutations in HIV Type 1 Subtypes B, C, and F Isolates from Brazilian Patients Failing HAART 10.1089/aid.2008.0160 2009
Altered immunological reactivity in HIV-1-exposed uninfected neonates 10.1016/j.clim.2008.01.020 2008
Phylogenetic and Genetic Analysis of Feline Immunodeficiency Virus gag, pol, and env Genes from Domestic Cats Undergoing Nucleoside Reverse Transcriptase Inhibitor Treatment or Treatment-Naive Cats in Rio de Janeiro, Brazil 10.1128/JVI.00310-08 2008
False I50V resistance readings of HIV isolates: co-amplification of NASBA HIV-1 RNA QT internal calibrators and HIV-1 patient isolates may lead to a false I50V mutation resistance reading in genotypic tests 10.1007/s00705-008-0138-2 2008
Drug Resistance Mutation Profile and Accumulation Kinetics in Human Immunodeficiency Virus-Positive Individuals Infected with Subtypes B and F Failing Highly Active Antiretroviral Therapy Are Influenced by Different Viral Codon Usage Patterns 10.1128/AAC.00820-08 2008
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique 10.1007/s00705-008-0215-6 2008
Molecular dynamics analysis of HIV-1 matrix protein: Clarifying differences between crystallographic and solution structures 10.1016/j.jmgm.2006.09.009 2007
Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor ?? production 10.1097/QAD.0b013e3282ca83fa 2007
Biological characterization of human immunodeficiency virus type 1 subtype C protease carrying indinavir drug-resistance mutations 10.1099/vir.0.81517-0 2006
Gag-Pol bearing a reverse transcriptase drug-resistant mutation influences viral genomic RNA incorporation into human immunodeficiency virus type 1 particles 10.1099/vir.0.82046-0 2006
Development of a New Methodology for Screening of Human Immunodeficiency Virus Type 1 Microbicides Based on Real-Time PCR Quantification 10.1128/AAC.00749-06 2006
Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism. 2005
Impact of Nelfinavir Resistance Mutations on In Vitro Phenotype, Fitness, and Replication Capacity of Human Immunodeficiency Virus Type 1 with Subtype B and C Proteases. 2004
Crystallization of a non-B and a B mutant HIV protease. 2004
Primary HIV-1 drug resistance in Brazil. 2004
Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. 2004
Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. 2004
In Vitro Hypersusceptibility of Human Immunodeficiency Virus Type 1 Subtype C Protease to Lopinavir. 2003
Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. 2003
Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors. 2003
A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. 2003
Testing Genotypic and Phenotypic Resistance in Human Immunodeficiency Virus Type 1 Isolates of Clade B and Other Clades from Children Failing Antiretroviral Therapy. 2002
Sexual transmission of HIV-1 isolate showing G->A hypermutation 2002
Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance 2001
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART 2001
A New Approach for Developing a Selectable Live-Attenuated Human Immunodeficiency Virus 2000
Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART. 2000
Construction of a selectable nef-defective live-attenuated human immunodeficiency virus expressing Escherichia coli gpt gene. 2000
HIV-1 Subtypes Among Blood Donors from Rio de Janeiro, Brazil 1999
Sequence Diversity of Tthe Reverse Transcriptase of Human Immunodeficiency Virus Type-1 from Untreated Brazilian Individuals 1999
N-Terminal Aminoacids are Essential for Foot-and-Mouth Disease Virus Replicase Activity 1992
In Vitro Activities of Recombinant Foot-and-Mouth Disease Virus Replicase Expressed in E.coli 1992
Site Directed Mutagenesis of The Foot-and-Mouth Disease Virus RNA Polymerase 1991
Expression of an Active Foot-and-Mouth Disease Virus RNA Polymerase ins E.coli 1991
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Genotyping and phenotyping analysis of B and nonB HIV-1 subtypes from patients under HAART 1997
Clonagem do gene da proteina de matriz p17 de HIV-1 subtipo B de isolado brasileiro 1995
Characterization of HIV-1 dual infection in patients of Rio de Janeiro 1995
Structure -function relationships of FMDV RNA polymerase: evidence for in vitro cooperation among enzyme molecules 1994
Development of a foot and mouth disease virus RNA pol with lost activity 1992
In vitro activities of a recombinant FMDV replicase expressed in E coli 1992
Utilization of a picornaviral replicase as a target of intracellular immunization 1992
Expression in E coli of the DNA containing the complete sequence of foot and mouth disease virus RNA pol gene 1991
Utilization of Genetic engeneering techniques for controlling foot and mouth disease 1989
Publicações:
Minha Rede: